Clinical trials for Lymphoma
104 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 2
Lymphoma
#NCT04984837
#2024-513252-15-00
Required histologic types
T cell lymphoma
Required histologic sub types
Peripheral T cell lymphoma
Required central nervous system lesions
None
Required renal function statuses
> 60 ml/min
50-60 ml/min
30-50 ml/min
Required number of previous lines of therapy
1
2
Required previous treatments
Chemotherapy
Excluded previous treatments
Systemic Treatment-Naive
Allogeneic stem cell transplant
1 recruiting site
The Lymphoma Academic Research Organisation (LYSARC)
Phase 2
Lymphoma
Brain tumors / Central nervous system tumors
#NCT03328078
#2024-513312-95-00
Required histologic types
B cell lymphoma
Other primary CNS tumor
Required histologic sub types
Primary cerebral lymphoma
Primary CNS lymphoma
Required number of previous lines of therapy
1
2
3 or more
Excluded previous treatments
Systemic Treatment-Naive
4 recruiting sites
Curis, Inc.
Phase 2
Lymphoma
#NCT05463263
Required histologic types
B cell lymphoma
T cell lymphoma
Required central nervous system lesions
None
Required number of previous lines of therapy
2
3 or more
Excluded previous treatments
Systemic Treatment-Naive
5 recruiting sites
Step Pharma, SAS
Phase 2
Lymphoma
#NCT06271057
#2023-506705-20-00
Required histologic types
B cell lymphoma
Required histologic sub types
Large B cell lymphoma
Primary mediastinal lymphoma
Indolent transformed lymphoma
Required renal function statuses
> 60 ml/min
Required number of previous lines of therapy
2
3 or more
Excluded previous treatments
Systemic Treatment-Naive
13 recruiting sites
The Lymphoma Academic Research Organisation (LYSARC)
Phase 2
Lymphoma
CLL & Richter's syndrome
Acute leukemia
Myelodysplastic Syndromes (MDS) and Myeloproliferative Neoplasms (MPN)
Multiple myeloma
#NCT04935684
Required histologic types
B cell lymphoma
T cell lymphoma
Hodgkin lymphoma
CLL (Chronic Lymphocytic Leukemia)
Symptomatic multiple myeloma
Required number of previous lines of therapy
1
2
3 or more
Required previous treatments
Allogeneic stem cell transplant
Excluded previous treatments
Systemic Treatment-Naive
4 recruiting sites
CHU de Clermont-Ferrand
Phase 2
Lymphoma
CLL & Richter's syndrome
#NCT07221500
#2025-521088-10-00
Required histologic types
B cell lymphoma
CLL (Chronic Lymphocytic Leukemia)
Required histologic sub types
Lymphocytic lymphoma
Required number of previous lines of therapy
1
2
3 or more
Required previous treatments
Targeted therapy
Excluded previous treatments
Car-T
1 recruiting site
Nurix Therapeutics, Inc.
Phase 2
Lymphoma
#NCT04844866
Required histologic types
B cell lymphoma
Required histologic sub types
Large B cell lymphoma
Primary mediastinal lymphoma
Follicular lymphoma
Indolent transformed lymphoma
Required central nervous system lesions
None
Required number of previous lines of therapy
1
Required previous treatments
Chemotherapy
Targeted therapy
Excluded previous treatments
Systemic Treatment-Naive
Car-T
5 recruiting sites
Miltenyi Biomedicine GmbH
Phase 2
Lymphoma
#NCT06547866
Required histologic types
B cell lymphoma
Required histologic sub types
Waldenström lymphoma
Required central nervous system lesions
None
Treated / Controled
Required renal function statuses
> 60 ml/min
50-60 ml/min
Required number of previous lines of therapy
1
2
3 or more
Excluded previous treatments
Systemic Treatment-Naive
6 recruiting sites
French Innovative Leukemia Organisation (FILO)
Phase 2
Lymphoma
#NCT06931652
#2023-505834-84-00
Required histologic types
B cell lymphoma
Required histologic sub types
Primary cerebral lymphoma
Required central nervous system lesions
Actives
Required renal function statuses
> 60 ml/min
50-60 ml/min
30-50 ml/min
Required number of previous lines of therapy
1
2
3 or more
Required previous treatments
Chemotherapy
Excluded previous treatments
Systemic Treatment-Naive
Bispecific T-cell engager antibodies
Allogeneic stem cell transplant
7 recruiting sites
The Lymphoma Academic Research Organisation (LYSARC)
Phase 2
Lymphoma
#NCT06534437
#2024-513098-31-00
Required histologic types
B cell lymphoma
Required histologic sub types
Large B cell lymphoma
Indolent transformed lymphoma
Required central nervous system lesions
None
Required number of previous lines of therapy
2
3 or more
Required previous treatments
Chemotherapy
Bispecific T-cell engager antibodies
Monoclonal antibodies
Excluded previous treatments
Systemic Treatment-Naive
7 recruiting sites
Ryvu Therapeutics SA